Pharmaceutical Commerce

Fast-Tracking the Future

Embarking on the CAR-T Journey

Selecting the Right 3PL

A Closer Look Into the Role of Compounding Pharmacies

The Path Forward for Infused Biosimilars in the US

Nov. 27 is Here: What Does That Mean for DSCSA?

The Impact of RFID: Enhancing Medication Management

Incorporating AI into Commercialization Plans

The Capabilities of a 3PL Provider

Addressing the Drug Shortage Crisis

Navigating Market Access Hurdles

Overcoming Supply Chain Challenges

Mitigating Drug Shortages

A Further Examination of Pharmacy Benefit Managers

A First-Hand Account of 3PLs

Complying With the DSCSA

Treating Psoriasis While Providing Patient Support

A Year in Review

Implementing Sustainable Business Practices

Supply Chain Safeguards

ESG Evolution

The DSCSA Overview

Protecting Patient Access to Medication in the Midst of Crisis

Using Pharmacovigilance Platforms to One’s Advantage

Safely Collecting Patient Data

Achieving Success in the Rare Disease Space

The Evolution of the Cold Chain Logistics Industry

Insights on Insight Gathering

The Intricacies of the Pharma Cold Chain

Tackling Specialty Conditions and Side Effects Simultaneously

The Co-existence of Commercialization and Patient Support

Lowering Lead Times, Controlling Costs, Retaining Talent

Understanding the Patient Journey in Complex and Rare Diseases

Intertwining Technology and Data Solutions

Making the Commercialization Process Worthwhile

Addressing Rising Rx Costs

Prioritizing American Manufacturing

Re-evaluating the Role of the Pharmacist

Providing Medication Access to Africa

Advancing Pharmacovigilance

Promoting Effective Patient Support

Enhancing Conversational AI

Seeking Better Patient Engagement

RWD ‘Fitness’ Steps for Pharma

M&A Milestones: The Covid Impact

Solving the Drug Pricing Conundrum

Diversity and Disruption in Clinical Research

Diagnostic Testing During a Pandemic

A Check-in with Chip Davis

Democratizing Reproductive Treatments for All